Thoughtful delivery service

Easy 30 day returns

Certified Reviews

Description

PE132010: β-GalNAc-PEG3-AcidC15H27NO10 381. 38 A D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG3 spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the

and lectin (e

β-D-Gal-Ethyl-Amine

8-di-piperidin-1-yl-pyrimido[5

6-dioxaoctyl) 2-acetamido-2-deoxy-β-D-galactopyranoside

Sialyl Tn or STn (Neu5Acα2-6GalNAcα-O-Ser) at Ser140 and Neu5Acα2-6GalNAcα-O-Thr at Thr139

38 / A β-D-N-acetylglucosamine (GlcNAcβ) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG3 spacer

/ GlcNAcβ(1-4)GlcNAc-β-Propyl-PEG4-DBCO / GlcNAcβ(1-4)GlcNAc-β-NH-(CH2)3-NHCO-PEG4-DBCO

enabling straightforward spectrophotometric assays of enzyme activity in solution and in high-throughput screening formats

04 / A triantennary N-acetylgalactosamine (Tri-GalNAcβ) ligand presenting three β-GalNAc residues on a tris-based branched scaffold

and in high-throughput screening formats

Methyl Ester)

15 / An Fmoc-protected L-serine building block carrying a branched Galβ1-3[GlcNAcβ1-6]GalNAcα trisaccharide